# Bank of Montreal: financial statements, quarterly

BMO · NYSE · CIK 927971 · [Financials](/sectors/financials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/bmo.md) · [Financials](/companies/bmo/financials.md) · [Filings](/companies/bmo/filings.md) · [Insiders](/companies/bmo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bmo/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-10-31) | period not labelled (2016-10-31) | period not labelled (2017-10-31) | FY2018 (2018-10-31) | FY2019 (2019-10-31) | FY2020 (2020-10-31) | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [40.3](/filings/0001193125-18-342247.md) | [31.7](/filings/0001193125-19-305402.md) | [32.6](/filings/0001193125-20-307333.md) | [42.1](/filings/0001193125-21-347995.md) | [48.8](/filings/0001193125-21-347995.md) | [57.4](/filings/0001193125-22-296674.md) | [93.3](/filings/0001193125-23-287420.md) | [87.5](/filings/0001193125-24-271395.md) | [77.9](/filings/0001193125-25-307982.md) | [65.1](/filings/0001193125-25-321328.md) | [67.5](/filings/0001193125-25-321328.md) |
| Total assets | $bn | not reported | not reported | [710](/filings/0001193125-18-342247.md) | [773](/filings/0001193125-19-305402.md) | [852](/filings/0001193125-20-307333.md) | [949](/filings/0001193125-21-347995.md) | [988](/filings/0001193125-22-296674.md) | [1,139](/filings/0001193125-23-287420.md) | [1,347](/filings/0001193125-24-271395.md) | [1,410](/filings/0001193125-25-321328.md) | [1,477](/filings/0001193125-25-321328.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | [893](/filings/0001193125-21-347995.md) | [931](/filings/0001193125-22-296674.md) | [1,068](/filings/0001193125-23-287420.md) | [1,271](/filings/0001193125-24-271395.md) | [1,325](/filings/0001193125-25-307982.md) | [1,389](/filings/0001193125-25-307982.md) |
| Shareholders' equity | $bn | not reported | [42.3](/filings/0001193125-18-342247.md) | [44.3](/filings/0001193125-19-305402.md) | [45.7](/filings/0001193125-20-307333.md) | [51.1](/filings/0001193125-21-347995.md) | [56.6](/filings/0001193125-21-347995.md) | [57.5](/filings/0001193125-22-296674.md) | [71.0](/filings/0001193125-23-287420.md) | [76.1](/filings/0001193125-24-271395.md) | [84.3](/filings/0001193125-25-307982.md) | [88.1](/filings/0001193125-25-307982.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 708,905,679 at 2025-10-31, from the cover of the [40-F filed 2025-12-04](/filings/0001193125-25-307982.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.